RxDoctor Payments Data

Thomas Petryk, MD

Family Medicine · Newark, OHNPI 1245210244

Payments from drug & device makers

$808in general payments, 2019–2025

Across 50 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$113
  • E.r. Squibb & Sons, L.L.C.$91
  • AbbVie$75
  • Pfizer$74
  • Novo Nordisk$72
  • Sunovion Pharmaceuticals Inc.$53
  • plus $330 from 13 others

What the payments were for

  • Food & beverage$808100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$808 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$358,187
Medicare patients
633
Services billed
11,614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban533$382,291
FarxigaDapagliflozin Propanediol177$136,132
OzempicSemaglutide74$100,003
TrulicityDulaglutide62$92,162
JardianceEmpagliflozin140$84,429
XareltoRivaroxaban63$66,613
XifaxanRifaximin17$53,735
AristadaAripiprazole Lauroxil13$43,111
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$40,361
JanuviaSitagliptin Phosphate44$31,974
Risperdal ConstaRisperidone Microspheres26$31,741
ProliaDenosumab16$27,962
Rufinamide13$27,671
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog35$25,275
Fiasp FlextouchInsulin Aspart (Niacinamide)50$22,346

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$74$382,291533 claims
AstraZenecaFarxiga, Byetta, Lokelma$14$165,208205 claims
Novo NordiskOzempic$72$100,00374 claims
Johnson & JohnsonXarelto, Risperdal Consta$13$98,35389 claims
Lilly USA, LLCTrulicity$38$92,16262 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$44$61,15184 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$33$53,73517 claims
MerckJanuvia$16$31,97444 claims
AbbVieLinzess, Creon$75$28,81635 claims
Astellas Pharma US IncMyrbetriq$17$9,99631 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Newark

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →